Big 4 Private Equity Firms In Brighter Mood; Falling Investment In Biotech
Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...
China regulatory easing hopes brighten outlook for offshore equity fundraising
Chinese companies are tapping into a rebound in investor sentiment fueled by hopes of Beijing's support for private firms and ...
Transatlantic capital flight may land in euro periphery
If a policy-driven turnaround in Europe's biggest economy tempts the continent's equity investors home, they may want to look ...
Private Equity, Venture Capital Flows To Biotechnology Lowest Since 2019
In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...
Bisnow9d
How Private Equity Is Leveraging Life Insurance To Increase Its CRE Foothold
Asset management giants like Apollo, BlackRock and Blackstone have inflated their assets through acquiring life insurers, one ...
Navigating Private Equity Secondaries In An Era Of Changing Interest Rates
As stakeholders recalibrate their approaches, secondaries offer a proving ground for innovative capital strategies that could influence private equity far into the future.
PE Hub13d
GPs skeptical of European IPO revival; Private capital ‘crucial’ in UK nuclear energy development
Stock markets might be on a tear and equity capital markets open, but European private equity firms are skeptical that the continent’s IPO market will offer a viable exit route in 2025 ...